Anaphylaxis - Education

Kaiser Permanente School of Anesthesia
2 Mar 201605:31

Summary

TLDRAnaphylaxis is a severe allergic reaction resulting from mast cell and basophil degranulation upon antigen exposure. It can manifest with life-threatening symptoms in respiratory, cardiovascular, and integumentary systems, varying in onset and severity. Common triggers during anesthesia include neuromuscular blockers and antibiotics. Immediate treatment involves calling for help, administering epinephrine, securing an airway, and providing fluids, with histamine blockers and steroids as adjunctive therapies.

Takeaways

  • 🚨 Anaphylaxis is a severe allergic reaction resulting from the degranulation of sensitized mast cells and basophils upon antigen exposure.
  • 🔬 Mast cells are found in the perivascular spaces of the skin and intestine, while basophils are in the blood.
  • 🌟 Immunoglobulin E (IgE) is produced on initial exposure to an antigen and binds to the effector cells' surface, triggering a response on subsequent exposures.
  • 💊 Physiologically active mediators like histamine, tryptase, and platelet-activating factor are released during anaphylaxis.
  • 🌡 Histamine is a key inflammatory mediator stored in mast cells and basophils, causing vasodilation, increased vascular permeability, and other symptoms.
  • 🚑 Symptoms of anaphylaxis can be life-threatening, affecting the respiratory, cardiovascular, and integumentary systems.
  • 💉 An anaphylactic reaction can occur on first exposure to certain drugs, such as anaesthetics, due to cross-reactivity.
  • 🕒 The onset and severity of anaphylactic symptoms can vary, complicating diagnosis, and may be masked by general anesthesia or surgical drapes.
  • 📊 Neuromuscular blocking agents are the most common triggers for an anaphylactic reaction during anesthesia, accounting for over 50% of incidents.
  • 🏥 Immediate treatment for anaphylaxis is critical and includes calling for help, administering epinephrine, securing an airway, and providing fluids.
  • 🛡 Epinephrine is crucial in anaphylaxis treatment due to its hemodynamic effects and ability to stabilize mast cells, reducing mediator release.

Q & A

  • What is anaphylaxis?

    -Anaphylaxis is a severe hypersensitivity reaction caused by the degranulation of sensitized mast cells and basophils after exposure to an antigen.

  • Where are mast cells and basophils typically located in the body?

    -Mast cells are located in the perivascular spaces of the skin, long intestine, and other tissues, while basophils are found in the blood.

  • What is the role of immunoglobulin E (IgE) in anaphylaxis?

    -IgE is produced upon initial exposure to an antigen and binds to the surface of effector cells, such as mast cells and basophils. Upon subsequent exposure, the antigen binds to the IgE, triggering the release of physiologically active mediators.

  • What are some of the physiologically active mediators released during an anaphylactic reaction?

    -During an anaphylactic reaction, mediators such as histamine, tryptase, chemotactic factors, platelet-activating factor, prostaglandins, leukotrienes, and cytokines are synthesized and released.

  • How does histamine contribute to the clinical signs and symptoms of anaphylaxis?

    -Histamine, stored in granules within mast cells and basophils, is a primary inflammatory mediator that works on receptors to cause vasodilation, increased vascular permeability, contraction of most smooth muscles, cardiac stimulation, and gastric secretions, leading to various symptoms of anaphylaxis.

  • Which systems of the body are most notably affected by an anaphylactic reaction?

    -The respiratory, cardiovascular, and integumentary systems are most notably affected by an anaphylactic reaction.

  • Can an anaphylactic reaction occur on first exposure to certain substances?

    -Yes, an anaphylactic reaction can occur on first exposure to certain substances, such as anaesthetic medications, due to cross-reactivity among many drugs and commercial household products.

  • What are some common triggering agents for an anaphylactic reaction during anesthesia?

    -Neuromuscular blocking agents are the most common triggering agents, accounting for more than fifty percent of incidents. Other causative agents include latex, antibiotics, colloids, hypnotics, contrast media, protamine, and opioids.

  • What are the signs and symptoms of an anaphylactic reaction?

    -Signs and symptoms include angioedema, laryngeal edema, hypotension, tachycardia, dysrhythmias, wheezing, bronchospasm, and a shock-like state secondary to severe hypotension.

  • What is the role of tryptase in an anaphylactic reaction?

    -Tryptase is an enzyme released from mast cells along with histamine and serves as a positive indicator for an immunologically mediated event when levels are greater than 25 micrograms per liter.

  • What is the immediate treatment for an anaphylactic reaction?

    -Immediate treatment includes calling for help, removing potential causative agents, increasing FIO2 to 100%, administering epinephrine, establishing a secure airway, ensuring adequate IV access, and providing a fluid bolus. An epinephrine infusion may be considered if there is no response to initial interventions.

  • Why is epinephrine a crucial part of anaphylaxis treatment?

    -Epinephrine is crucial due to its positive hemodynamic effects and its ability to stabilize mast cells and reduce the amount of inflammatory mediator release.

  • What are some other treatment options for anaphylaxis besides epinephrine?

    -Other treatment options include vasopressors, beta-2 agonists, histamine blockers, and steroids to counteract the effects of histamine and assist in reversing hypotension refractory to epinephrine and intravascular fluid replacement.

Outlines

00:00

🚨 Anaphylaxis: Causes and Symptoms

Anaphylaxis is a severe allergic reaction triggered by antigen exposure to sensitized mast cells and basophils. These cells release inflammatory mediators like histamine, tryptase, and leukotrienes upon antigen binding to IgE antibodies. This leads to various symptoms, notably affecting the respiratory, cardiovascular, and integumentary systems. Symptoms can range from angioedema to hypotension and bronchospasm, and it can be life-threatening. The reaction can occur with the first exposure to certain drugs, including anesthetics, and diagnosis can be complicated by variable onset times and masked symptoms under general anesthesia. Common triggers during anesthesia are neuromuscular blocking agents, latex, antibiotics, and others, accounting for over 50% of incidents.

05:01

💡 Anaphylaxis Treatment and Management

Immediate treatment for anaphylaxis is crucial and involves calling for help, removing the causative agent, administering 100% oxygen, and giving epinephrine. Establishing a secure airway and ensuring IV access are also critical. If there's no response, an epinephrine infusion may be necessary. Additional treatments may include vasopressors, beta-2 agonists, histamine blockers, and steroids. Tryptase levels can indicate an immunologically mediated event and are useful for diagnosis, but normal levels do not rule out anaphylaxis. Glucocorticoids may help prevent recurring or prolonged reactions, and H1 and H2 receptor antagonists can counteract histamine effects, aiding in the management of symptoms like urticaria and angioedema.

Mindmap

Keywords

💡Anaphylaxis

Anaphylaxis is a severe, life-threatening allergic reaction that occurs rapidly after exposure to an allergen. It is characterized by the degranulation of sensitized mast cells and basophils, which release a variety of inflammatory mediators. The video script discusses anaphylaxis in the context of its occurrence during anesthesia and the importance of prompt recognition and treatment. The term is central to the video's theme, illustrating the potential dangers of allergic reactions and their management.

💡Mast Cells

Mast cells are immune cells that play a key role in anaphylaxis. They are found in various tissues, including the skin and intestine, and contain granules filled with inflammatory mediators. Upon exposure to an antigen, mast cells degranulate, releasing these mediators. In the script, mast cells are mentioned as the primary cells involved in the initial response to an antigen, leading to anaphylactic symptoms.

💡Basophils

Basophils are a type of white blood cell found in the blood. Similar to mast cells, they are involved in anaphylactic reactions by releasing histamine and other mediators upon exposure to an antigen. The script notes that basophils, along with mast cells, are responsible for the release of physiologically active mediators that cause the symptoms of anaphylaxis.

💡Immunoglobulin E (IgE)

Immunoglobulin E, or IgE, is an antibody that the body produces in response to allergens. It binds to the surface of effector cells like mast cells and basophils. The script explains that upon initial exposure to an antigen, IgE is produced, which upon subsequent exposure, leads to the release of mediators causing anaphylaxis. IgE is a crucial component in the pathophysiology of anaphylactic reactions.

💡Histamine

Histamine is a primary inflammatory mediator stored in granules within mast cells and basophils. It plays a significant role in the clinical signs and symptoms of anaphylaxis by causing vasodilation, increased vascular permeability, and smooth muscle contraction. The script describes histamine as a key player in the manifestation of anaphylactic symptoms, such as respiratory distress and cardiovascular issues.

💡Tryptase

Tryptase is an enzyme released from mast cells along with histamine during an anaphylactic reaction. It has a longer half-life and can be a positive indicator of an immunologically mediated event when present at levels greater than 25 micrograms per liter. The script mentions tryptase as a diagnostic tool for anaphylaxis, despite the fact that normal levels do not rule out the condition.

💡Neuromuscular Blocking Agents

Neuromuscular blocking agents are medications used during anesthesia to induce muscle paralysis. The script identifies these agents as the most common triggering agents for an anaphylactic reaction during anesthesia, accounting for more than fifty percent of the incidents. This highlights the particular risk associated with these drugs in the context of anesthetic procedures.

💡Epinephrine

Epinephrine, also known as adrenaline, is a hormone and medication that is critical in the treatment of anaphylaxis. It has positive hemodynamic effects and helps stabilize mast cells, reducing the release of inflammatory mediators. The script emphasizes the importance of administering epinephrine promptly in the case of an anaphylactic reaction, as it can be life-saving.

💡Vasopressors

Vasopressors are medications that constrict blood vessels and increase blood pressure. In the context of anaphylaxis, they may be used if there is no response to initial treatments like epinephrine. The script suggests considering vasopressors as part of the treatment options for severe anaphylactic shock.

💡Beta-2 Agonists

Beta-2 agonists are a class of medications that relax the smooth muscles of the lungs, increasing airflow. They may be used in the treatment of anaphylaxis to counteract symptoms like wheezing and bronchospasm. The script mentions beta-2 agonists as a treatment option to consider, particularly for respiratory symptoms of an anaphylactic reaction.

💡Glucocorticoids

Glucocorticoids, or steroids, are a class of medications with potent anti-inflammatory effects. They may be used in the treatment of anaphylaxis to reduce the risk of recurring or prolonged symptoms. The script notes that glucocorticoids can be administered to help manage the inflammatory response during an anaphylactic reaction.

Highlights

Anaphylaxis is a severe hypersensitivity reaction caused by degranulation of sensitized mast cells and basophils after exposure to an antigen.

Mast cells are located in the perivascular spaces of the skin, long intestine, while basophils are in the blood.

Immunoglobulin E (IgE) is produced upon initial exposure to an antigen and binds to the surface of effector cells.

Subsequent exposure to the antigen leads to the release of physiologically active mediators, including histamine.

Histamine is a primary inflammatory mediator stored in granules within mast cells and basophils.

Histamine causes vasodilation, increased vascular permeability, and smooth muscle contraction, leading to anaphylactic symptoms.

Anaphylactic reactions can occur in the respiratory, cardiovascular, and integumentary systems.

An anaphylactic reaction can occur on first exposure to certain medications due to cross-reactivity.

The onset and degree of clinical manifestations can vary greatly, complicating diagnosis.

Neuromuscular blocking agents are the most common triggering agents for an anaphylactic reaction during anesthesia.

Signs and symptoms of an anaphylactic reaction include angioedema, laryngeal edema, hypotension, and tachycardia.

A shock-like state can develop due to severe hypotension caused by vasodilation and fluid extravasation.

Tryptase is an enzyme released from mast cells and can be a positive indicator for an immunologically mediated event.

Anaphylactic reactions are life-threatening and require prompt identification and immediate treatment.

Treatment for anaphylaxis includes calling for help, removing causative agents, and administering epinephrine.

Epinephrine has positive hemodynamic effects and stabilizes mast cells, reducing inflammatory mediator release.

H1 and H2 receptor antagonists are used to counteract the effects of histamine and may assist in reversing hypotension.

Glucocorticoids may reduce the risk of recurring or prolonged anaphylaxis.

Transcripts

play00:01

anaphylaxis is a severe hypersensitivity

play00:04

reaction caused by the degranulation of

play00:07

sensitized mast cells and basophils

play00:09

after exposure to an antigen mast cells

play00:13

are located in the perivascular spaces

play00:15

of the skin long and intestine while

play00:19

basophils are located in the blood upon

play00:22

initial exposure to an antigen

play00:24

immunoglobulin E is produced and binds

play00:27

to the surface of the effector cell with

play00:30

subsequent exposure the antigen binds to

play00:33

the IgE antibodies releasing

play00:35

physiologically active mediators that

play00:37

include histamine tryptase chemotactic

play00:41

factors and platelet-activating factor

play00:45

furthermore metabolites such as

play00:47

prostaglandins kinase leukotrienes and

play00:51

cytokines are synthesized and released

play00:54

histamine is a primary inflammatory

play00:56

mediator which is stored in granules

play00:58

within the mast cells and basophils

play01:01

histamine has an important role in the

play01:03

clinical signs and symptoms manifested

play01:06

in anaphylaxis and works on receptors to

play01:09

cause vasodilation increased vascular

play01:11

permeability contraction of most smooth

play01:14

muscle other than blood vessels cardiac

play01:17

stimulation and stimulation of gastric

play01:20

secretions this results in a series of

play01:24

potentially life-threatening symptoms

play01:25

occurring most notably in the

play01:27

respiratory cardiovascular and

play01:29

integumentary systems it is possible for

play01:33

an anaphylactic reaction to occur on

play01:35

first exposure to anaesthetic

play01:36

medications due to cross reactivity

play01:38

among many drugs and commercial

play01:41

household products the time of onset and

play01:45

the degree of clinical manifestations

play01:47

can vary greatly making diagnosis

play01:49

complicated in addition many symptoms

play01:52

may be masked by general anesthesia and

play01:54

the use of surgical drapes which conceal

play01:57

the cutaneous signs the most common

play02:00

triggering agents for an anaphylactic

play02:01

reaction during anesthesia are

play02:03

neuromuscular blocking agents they

play02:06

account for more than fifty percent of

play02:08

the total incidents other causative

play02:10

agents include latex antibiotics

play02:14

colloids hypnotics contrast media

play02:17

protamine and opioids there are also

play02:21

several other medications medication

play02:23

classes and substances that have the

play02:25

potential to trigger anaphylaxis the

play02:29

signs and symptoms of an anaphylactic

play02:30

reaction are the consequence of the

play02:33

antigen-antibody reaction and the body's

play02:35

massive immune response that includes

play02:38

the release of histamine as a result /

play02:41

itís or tocaria angioedema especially

play02:45

laryngeal edema hypotension tachycardia

play02:48

dysrhythmias wheezing and bronchospasm

play02:51

may occur a shock like state can develop

play02:55

that is secondary to severe hypotension

play02:57

caused by vasodilation and the

play03:00

extravasated of protein and fluids out

play03:02

of the vascular compartment the clinical

play03:06

appearance of anaphylaxis may present in

play03:08

various combinations and usually occurs

play03:10

within minutes of exposure to the

play03:12

offending antigen however in some cases

play03:15

the onset of signs and symptoms may be

play03:18

delayed for an hour or longer trip taste

play03:22

is an enzyme released from mast cells

play03:25

along with histamine and has a half-life

play03:27

of several hours it has been shown to be

play03:30

a positive indicator for an

play03:32

immunologically mediated event at levels

play03:34

greater than 25 micrograms per liter

play03:37

however the presence of normal trip

play03:40

taste levels should not rule out an

play03:42

anaphylactic reaction since normal

play03:44

levels have been found in up to

play03:46

one-third of anaphylactic cases

play03:49

anaphylactic reactions are

play03:50

life-threatening and require prompt

play03:53

identification and immediate treatment

play03:55

treatment includes calling for help

play03:59

removing potential causative agents

play04:02

increasing fio2 to 100% administering

play04:06

epinephrine establishing a secure airway

play04:09

and ensuring adequate IV access

play04:13

providing a fluid bolus if there's no

play04:17

response to these interventions an

play04:18

epinephrine infusion should be

play04:21

considered other treatment options to

play04:24

consider include vasopressors

play04:27

beta-2 agonists histamine blockers and

play04:30

steroids airway patency must be

play04:34

accomplished by means of intubation and

play04:36

maintained since a demon the airway is a

play04:39

common complication of anaphylaxis

play04:42

epinephrine should not be delayed due to

play04:45

its positive hemodynamic effects as well

play04:47

as its ability to stabilize mast cells

play04:49

and reduce the amount of inflammatory

play04:51

mediator release epinephrine can be

play04:54

administered intravenously or

play04:56

subcutaneously and the dose should be

play04:59

titrated according to the severity of

play05:01

symptoms and histamines may be useful

play05:04

particularly for symptoms of ERDA keria

play05:07

and angioedema h1 and h2 receptor

play05:10

antagonists are frequently administered

play05:13

to counteract the effects of histamine

play05:15

and may assist in reversing hypotension

play05:18

refractory to epinephrine and

play05:20

intravascular fluid replacement

play05:23

glucocorticoids may reduce the risk of

play05:25

recurring or prolonged anaphylaxis

Rate This

5.0 / 5 (0 votes)

Связанные теги
AnaphylaxisAllergic ReactionMast CellsIgE AntibodiesHistamineMedical EmergencyTreatment ProtocolEpinephrineImmune ResponseHealthcareAllergy Awareness
Вам нужно краткое изложение на английском?